Amylin is another molecular target being investigated in clinical trials for obesity owing to its role in regulating satiety
Bodo Baumeister Partner, Health Industries Consulting Leader, Basel, PwC Switzerland +41 58 792 1505 Partner, Strategy& Germany Joo Aguiar Machado Senior Manager, Advisory, PwC Switzerland +41 79 574 10 81
These medications are approved to treat obesity and/or type 2 diabetes
Why the new GLP-1 pill is such a big deal The FDA just approved Foundayo
As you get used to the medication and gastrointestinal side effects ease, slowly work in a few of your favorite foods that youve been missing, especially the more flavorful ones, not necessarily high-fat or high-sugar foods
Haseeb M, Chhatwal J, Xiao J, et al